- Home
- NGNE vs MAMA Comparison
NGNE vs MAMA Comparison
Compare NGNE & MAMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NGNE
- MAMA
- Stock Information
- Founded
- NGNE 2003
- MAMA 2010
- Country
- NGNE United States
- MAMA United States
- Employees
- NGNE N/A
- MAMA N/A
- Industry
- NGNE Biotechnology: Pharmaceutical Preparations
- MAMA Specialty Foods
- Sector
- NGNE Health Care
- MAMA Consumer Staples
- Exchange
- NGNE Nasdaq
- MAMA Nasdaq
- Market Cap
- NGNE 325.3M
- MAMA 323.1M
- IPO Year
- NGNE N/A
- MAMA N/A
- Fundamental
- Price
- NGNE $18.48
- MAMA $7.98
- Analyst Decision
- NGNE Strong Buy
- MAMA Strong Buy
- Analyst Count
- NGNE 7
- MAMA 3
- Target Price
- NGNE $41.86
- MAMA $10.33
- AVG Volume (30 Days)
- NGNE 110.1K
- MAMA 154.7K
- Earning Date
- NGNE 08-11-2025
- MAMA 09-08-2025
- Dividend Yield
- NGNE N/A
- MAMA N/A
- EPS Growth
- NGNE N/A
- MAMA N/A
- EPS
- NGNE N/A
- MAMA 0.11
- Revenue
- NGNE N/A
- MAMA $128,745,000.00
- Revenue This Year
- NGNE N/A
- MAMA $17.24
- Revenue Next Year
- NGNE N/A
- MAMA $9.95
- P/E Ratio
- NGNE N/A
- MAMA $72.57
- Revenue Growth
- NGNE N/A
- MAMA 17.04
- 52 Week Low
- NGNE $6.88
- MAMA $5.50
- 52 Week High
- NGNE $74.49
- MAMA $9.98
- Technical
- Relative Strength Index (RSI)
- NGNE 35.93
- MAMA 41.43
- Support Level
- NGNE $19.59
- MAMA $8.37
- Resistance Level
- NGNE $20.46
- MAMA $8.74
- Average True Range (ATR)
- NGNE 1.23
- MAMA 0.31
- MACD
- NGNE -0.20
- MAMA -0.00
- Stochastic Oscillator
- NGNE 13.37
- MAMA 10.11
About NGNE Neurogene Inc.
Neurogene Inc is a clinical-stage biotechnology company committed to overcoming the limitations of neurological diseases into treatable conditions, by harnessing its proprietary transgene regulation technology, EXACTTM (Expression Attenuation via Construct Tuning). It is building a differentiated product portfolio of genetic medicines for rare neurological diseases with high unmet needs. The drug candidates in the company's product pipeline include NGN-401, which is in development for the treatment of Rett syndrome, using its EXACT platform, and NGN-101, a non-EXACT, conventional gene therapy development candidate for the treatment of CLN5 Batten disease, designed to deliver the CLN5 gene and packaged in an AAV9 capsid.
About MAMA Mama's Creations Inc.
Mama's Creations Inc is a marketer and manufacturer of fresh deli-prepared foods, found in grocery, mass, club, and convenience stores nationally. The company's broad product portfolio, born from a rich history in Italian foods, now consists of a variety of high-quality, fresh, clean, and easy-to-prepare foods to address the needs of both consumers and retailers. The brand of the company includes Mama's Creations, Mama's Mancini's, The Olive Branch, Creative Salads, and others.